Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Cash flow from operating activities:    
Net loss $ (55,075) $ (74,550)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 8,727 5,638
Bad debt expense 1,161 47
Stock-based compensation expense, net of amounts capitalized 39,920 37,953
Non-cash interest paid in kind and discount amortization 0 3,266
Non-cash lease expense 4,759  
Deferred income taxes 0 1
Other non-cash items, net (549) (1,187)
Changes in operating assets and liabilities:    
Accounts receivable 29,358 12,741
Prepaid expenses and other current assets 27,246 (2,395)
Other noncurrent assets (5,782) (3,151)
Accounts payable (1,243) (5,774)
Operating lease right-of-use assets (5,448)  
Accrued expenses and other current liabilities (625) 16,413
Litigation settlement (12,000) 0
Deferred revenue (24,578) (7,132)
Other liabilities (1,285) 197
Net cash provided by (used in) operating activities 4,586 (17,933)
Cash flow from investing activities:    
Purchases of marketable securities (640,173) (61,758)
Sales of marketable securities 2,838 56,652
Maturities of marketable securities 459,026 197,555
Purchases of property and equipment (2,923) (5,197)
Capitalized internal-use software (7,733) (4,150)
Acquisitions, net of cash acquired 0 (3,625)
Net cash (used in) provided by investing activities (188,965) 179,477
Cash flow from financing activities:    
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts, commissions and other offering costs 0 275,973
Proceeds from issuance of common stock upon exercise of stock options 15,997 17,892
Proceeds from issuance of common stock upon ESPP purchases 6,213 0
Net cash provided by financing activities 22,210 293,865
Effect of exchange rate fluctuations on cash and cash equivalents (3,232) (1,060)
Net change in cash and cash equivalents (165,401) 454,349
Cash and cash equivalents at beginning of period 321,426 68,037
Cash and cash equivalents at end of period 156,025 522,386
Supplemental disclosure of cash flow information    
Cash paid for income taxes, net of refunds 5,137 2,525
Supplemental disclosure for non-cash investing and financing    
Net exercise of common stock warrants 0 18
Stock-based compensation expense capitalized in internal-use software 1,898 465
Accrued purchases of property and equipment 92 $ 126
Right of use assets obtained in exchange for operating lease liabilities $ 5,222